Ubs Asset Management Americas Inc Senseonics Holdings, Inc. Transaction History

Ubs Asset Management Americas Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.68 - $1.25 $147,052 - $270,317	-216,254 Reduced 52.57%	195,084 $138,000
Q3 2022 Nov 14, 2022	SELL	$1.02 - $2.23 $131,423 - $287,328	-128,847 Reduced 23.85%	411,338 $542,000
Q2 2022 Aug 12, 2022	BUY	$0.94 - $1.94 $78,718 - $162,461	83,743 Added 18.35%	540,185 $556,000
Q4 2021 Feb 14, 2022	BUY	$2.58 - $3.91 $294,545 - $446,385	114,165 Added 33.35%	456,442 $1.22 Million
Q3 2021 Nov 15, 2021	BUY	$2.77 - $4.05 $139,663 - $204,201	50,420 Added 17.28%	342,277 $1.16 Million
Q2 2021 Aug 16, 2021	BUY	$1.71 - $4.14 $499,075 - $1.21 Million	291,857 New	291,857 $1.12 Million
Q4 2019 Feb 14, 2020	SELL	$0.83 - $1.3 $61,279 - $95,980	-73,831 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.97 - $1.94 $9,871 - $19,743	10,177 Added 15.99%	73,831 $73,000
Q1 2019 May 14, 2019	BUY	$2.3 - $3.27 $8,510 - $12,099	3,700 Added 6.17%	63,654 $0
Q4 2018 Feb 13, 2019	BUY	$2.49 - $4.54 $149,285 - $272,191	59,954 New	59,954 $155,000

138

80.6M

418K

219K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $335M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.